Home » Topics » BioWorld

BioWorld
RSS

CALYPTE PRIVATE PLACEMENT RAISES $6.3 MILLION

April 13, 1992

AMVAX AWARDED U.S. CONTRACT FOR VACCINE

April 13, 1992

VENTURE FUNDS RAISE $188 MILLION

April 13, 1992

BIOGEN REVENUES DISAPPOINT WALL STREET

April 13, 1992

TRADING CLOSES MIXED ON FRIDAY

April 13, 1992

WEAK MARKET CAUSES RETREAT BY IPOS

April 13, 1992

ROBUST DAY FOR BIOTECH STOCKS

April 10, 1992

PROLEUKIN APPROVED IN AUSTRIA

April 10, 1992

BAXTER SETS BLOOD SUBSTITUTE TRIAL

April 10, 1992

CATVAX MOVING INTO THE CLINIC

April 10, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...